Document is current
Any future updates will be listed below
-
Authors
Marquez, Camila R.
Corbett, Megan C.
Shi, Vivian Y.
Rick, Jonathan W.
- License Information
-
More Information
Article History
Received: 9 September 2025
Accepted: 28 January 2026
First Online: 13 February 2026
Declarations
:
: Jonathan W. Rick - Incyte Pharmaceutical Corporation, prior contracted member of an advisory board. Vivian Y. Shi is on the board of directors for the Hidradenitis Suppurativa Foundation (HSF), an advisor for the National Eczema Association, is a stock shareholder of Learn Health and has served as an advisory board member, investigator, speaker, and/or received research funding from Sanofi Genzyme, Regeneron, AbbVie, Genentech, Eli Lilly, Novartis, SUN Pharma, LEO Pharma, Pfizer, Incyte, Dermavant, Apogee, Boehringer Ingelheim, Almirall, Alumis, Aristea Therapeutics, Menlo Therapeutics, Dermira, Burt’s Bees, Galderma, Kiniksa, UCB, Ceraclere, Target-PharmaSolutions, Castle Bioscience, Altus Lab/cQuell, MYOR, Polyfins Technology, GpSkin, Skin Actives Scientific, Oruka, Insmed, Arcutis, and Takeda. Camila R. Marquez & Megan C. Corbett have no financial or non-financial interests to disclose.
